Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis-Reference-Cited by-同舟云学术

Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis

Published:2023-11-09 Issue:12 Volume:20 Page:6345-6357
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Li Yaoqi¹,Zhu Jie¹,Yang Yifan¹,Chen Yitian¹,Liu Lishan¹,Tao Jing²,Chen Huabing¹³²^ORCID,Deng Yibin¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Neuropsychiatric Diseases, and College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China

2. Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006, China

3. State Key Laboratory of Radiation Medicine and Protection, and School of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China

Funder

Jiangsu Provincial Key Research and Development Program

National Key Research and Development Program of China

Science and Technology Program of Suzhou

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases, Soochow University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00746

Reference66 articles.

1. Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases

2. The current landscape of locally advanced rectal cancer

3. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data

4. The resurgence of platinum-based cancer chemotherapy

5. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells